Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 459.11M | 368.69M | 371.52M | 350.92M | 308.00M | 362.93M |
Gross Profit | 158.21M | 92.99M | 87.34M | 86.97M | 48.11M | 70.18M |
EBITDA | 148.76M | 105.22M | 106.95M | 91.83M | 74.53M | 109.14M |
Net Income | -15.24M | -5.29M | 23.01M | 25.54M | -4.60M | 18.59M |
Balance Sheet | ||||||
Total Assets | 439.96M | 439.96M | 469.37M | 464.47M | 444.39M | 508.05M |
Cash, Cash Equivalents and Short-Term Investments | 6.06M | 6.06M | 11.14M | 13.62M | 15.92M | 20.09M |
Total Debt | 193.24M | 193.24M | 204.03M | 201.86M | 194.71M | 251.75M |
Total Liabilities | 286.94M | 286.94M | 294.44M | 297.88M | 291.27M | 338.12M |
Stockholders Equity | 153.02M | 153.02M | 174.93M | 166.59M | 153.09M | 169.89M |
Cash Flow | ||||||
Free Cash Flow | 9.19M | 17.31M | 3.00M | 8.03M | 58.33M | 30.20M |
Operating Cash Flow | 107.49M | 89.64M | 66.31M | 76.71M | 104.92M | 84.89M |
Investing Cash Flow | -95.35M | -47.06M | -38.46M | -53.55M | -29.05M | -36.63M |
Financing Cash Flow | -39.36M | -47.63M | -30.49M | -25.49M | -73.86M | -45.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | £1.04B | 14.45 | 8.62% | 0.12% | 0.82% | -26.44% | |
70 Outperform | £64.18B | 20.09 | 15.72% | 1.55% | 2.11% | 3.37% | |
69 Neutral | £2.75B | 17.89 | 10.95% | 4.78% | -1.15% | -28.00% | |
68 Neutral | £2.99B | 10.39 | 7.71% | 3.37% | 3.01% | -10.61% | |
64 Neutral | £142.67M | ― | -0.65% | 10.32% | -4.08% | 29.90% | |
56 Neutral | £236.77M | 16.40 | 9.52% | 9.33% | -1.52% | -122.68% |